About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Promising Method to Treat Familial Dysautonomia Discovered

by Colleen Fleiss on May 2, 2018 at 2:03 AM
Font : A-A+

Promising Method to Treat Familial Dysautonomia Discovered

A synthetic piece of RNA enables human and mouse cells to produce normal levels of IKAP, despite the presence of the disease mutation, found researchers led by CSHL Professor Adrian Krainer, together with their collaborators at Ionis Pharmaceuticals.

The experiments, conducted in cells sampled from patients and in a mouse model of the disease, provide proof of the team's therapeutic concept. Familial dysautonomia, or FD, occurs primarily in people of Ashkenazi Jewish ancestry. It impairs the development and function of the autonomic nervous system, causing problems with involuntary body functions, such as breathing, digestion, and blood-pressure regulation.

Advertisement


Those affected carry a mutation in a gene called IKBKAP, which reduces cells' ability to produce the IKAP protein. The RNA-like molecule--known as an antisense oligonucleotide (ASO)--was injected into mice whose cells carry the human IKBKAP mutation that causes FD. It corrects an error in what scientists call RNA splicing that prevents people with FD from manufacturing sufficient functional IKAP protein. A drug based on the same ASO might be used to overcome the same mutation in people with familial dysautonomia, Krainer says. The findings, reported today in Nucleic Acids Research, come less than two years after the FDA approved nusinersen (marketed as Spinraza), an ASO that Krainer's lab developed in collaboration with Ionis Pharmaceuticals for the treatment of another neurodegenerative disorder called spinal muscular atrophy (SMA).

In their work on SMA, Krainer's team had shown that an ASO designed to bind to an RNA near a defective splice site could correct splicing and induce production of functional, full-length protein. They followed the same strategy in the newly published research on FD. They designed and screened dozens of ASOs that bind to IKBKAP's RNA, looking for one that most efficiently restored normal splicing. "We used the same chemistry as we did for Spinraza, because we know that drug is well tolerated and it's very effective and stable in the central nervous system," Krainer says.
Advertisement

The team demonstrated that when they administered the ASO to mice harboring the mutant human IKBKAP gene, it reached various tissues, including the nervous system, and corrected splicing. More importantly, it restored production of full-length IKAP protein. Further testing is needed to determine whether it will be appropriate to move the ASO into clinical trials. But following the success of nusinersen, Krainer is optimistic that his team has identified a promising strategy for potentially treating familial dysautonomia.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Health Benefits of Giloy
Breast Cancer Awareness Month 2021 - It's time to RISE
First-Ever Successful Pig-To-Human Kidney Transplantation
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
Alzheimers Disease
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and ......
New Antibody Test to Detect Proteins Implicated in Neurodegenerative Conditions
The antibody that binds to the tau-proteins, acts like a magnifying glass, amplifying tau levels so ...
Mutant Prion Protein Helps Reveal Neurodegenerative Disease Mechanisms
Mutant sheep scrapie prion lacks a stretch of amino acids that may be essential for infection....
Clumps of Neuron Killing Proteins Implicated in Neurodegenerative Disorders
Mutation in SOD1 leads to clumping of proteins that kill neuron cells in neurodegenerative diseases ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use